Uptake and Utilization of Amino Acids by Splanchnic Bed
NCT01032616 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2013-08-05
Summary
Splanchnic uptake and metabolism contributes significantly to the differences in flux seen between the intravenous and intragastric ingestion of certain indispensable amino acids.
This is the third in a series of studies designed to increase the investigators knowledge of the metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed. In the initial two studies the investigators established the neonatal parenteral requirement of threonine and lysine. In the current study, the investigators will be examining the differences in uptake and metabolism of threonine and lysine across the splanchnic bed.
Conditions
- Healthy Males
Interventions
- OTHER
-
Threonine Experimental: Study Period 1
Enteral and parenteral infusion of threonine isotope
- OTHER
-
Lysine Experimental: Study Period 2
Both intravenous (iv) and intragastric (ig) Lysine isotopes.
Sponsors & Collaborators
-
The Hospital for Sick Children
lead OTHER
Principal Investigators
-
Paul Pencharz, MD · The Hospital for Sick Children
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- Canada
Study Locations
More Related Trials
-
Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome
NCT03105362 ·Status: TERMINATED ·Phase: NA
-
Tolerance of an Oral Nutritional Supplement(ONS)
NCT01782456 ·Status: COMPLETED ·Phase: NA
-
Amino Acid Kinetics of GMP-AA in Healthy Human Volunteers
NCT05971563 ·Status: COMPLETED ·Phase: NA
-
Effects of Parenteral L-carnitine Supplementation in Premature Neonates
NCT00841295 ·Status: COMPLETED ·Phase: NA
-
Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism
NCT04248062 ·Status: COMPLETED
-
Role of the Gut Sweet Taste Receptor in the Secretion of Glucagon-like Peptide-1 and Peptide YY
NCT01304823 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolic Evaluation of Nutrition in Rett Syndrome
NCT00786071 ·Status: COMPLETED
-
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
NCT01576003 ·Status: COMPLETED ·Phase: NA
-
A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome
NCT01413425 ·Status: WITHDRAWN
-
Reference Values for Gastric Emptying
NCT02397577 ·Status: COMPLETED ·Phase: NA
-
Cysteine Supplementation in Critically Ill Neonates
NCT00254176 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Chromium Contamination of Parenteral Nutrition
NCT03906890 ·Status: COMPLETED
-
Oral Nutritional Supplementation in Children
NCT02125123 ·Status: TERMINATED ·Phase: NA
-
True Ileal Amino Acid Digestibility of Tenebrio Molitor Larvae in Women
NCT05885191 ·Status: COMPLETED ·Phase: NA
-
Study of Treatment and Metabolism in Patients With Urea Cycle Disorders
NCT00004307 ·Status: UNKNOWN ·Phase: PHASE1
-
cGMP: Metabolism and Appetite Modulation
NCT06794515 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Gastrointestinal Dysmotility on Aspiration Risk
NCT05455359 ·Status: RECRUITING ·Phase: PHASE4
-
The Role of Dietary Calcium for the Treatment of Osteopenia in Girls With Rett Syndrome
NCT05352373 ·Status: COMPLETED ·Phase: NA
-
Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides
NCT01302574 ·Status: COMPLETED ·Phase: PHASE1
-
Lanreotide in the Treatment of Small Bowel Motility Disorders
NCT03012594 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Acetaminophen Toxicity With N-acetylcysteine
NCT00725179 ·Status: COMPLETED
-
Additional Dietary Large Neutral Amino Acids (LNAA) for Improved Symptoms in Adult Classical Phenylktonuria (PKU)
NCT05174559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY
NCT01088841 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria
NCT02110147 ·Status: COMPLETED ·Phase: PHASE3
-
Intratracheal Vitamin A Administration With Surfactant for Newborn Respiratory Distress Syndrome
NCT01265589 ·Status: UNKNOWN ·Phase: PHASE3